Breaking News
Get 45% Off 0
🚨 Don’t miss your updated list of AI-picked stocks for this month
Pick Stocks with AI

Search Results for "biomarin":

Results: 501

Quotes

BMRN Biomarin Pharmaceutical Inc Stock - NASDAQ equities AKBM Aker Biomarine AS Stock - Oslo equities B1MR34 Biomarin Pharmaceutical Inc Stock - B3 equities BMRN Biomarin Pharmaceutical Inc Stock - Vienna equities AKBMNOK Aker Biomarine AS Stock - Stockholm equities 1BMRN Biomarin Pharmaceutical Inc Stock - Milan equities BMRN Biomarin Pharmaceutical Inc Stock - TradeGate equities
Show all (7)

News

BioMarin's PALYNZIQ shows promise for adolescents with PKU
By Investing.com

SAN RAFAEL, Calif. - BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), a biotechnology company with a market capitalization of $12.96 billion and impressive gross margins of nearly 80%, announced on Monday...

BioMarin pharmaceutical CAO Erin Burkhart sells $92,618 in stock
By Investing.com

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) recently reported that Erin Burkhart, the company's Group Vice President and Chief Accounting Officer, sold a portion of her holdings in the company....

Citi maintains Neutral on BioMarin stock, price target at $82
By Investing.com

On Thursday, Citi analysts, led by David Lebowitz, reaffirmed a Neutral rating on shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), maintaining the price target at $82.00. According to...

Show all (231)

Analysis

BioMarin Begins Pediatric Study On Achondroplasia Candidate
By Zacks Investment Research

BioMarin Pharmaceutical Inc (NASDAQ:CRSP) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks hereCRISPR Therapeutics’ loss per share...

BioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 7.5%
By Zacks Investment Research

BioMarin Pharmaceutical Inc. (NASDAQ:EBS) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Is BMRN going up? Or down? Predict to see...

Biotech Stock To Watch: Sarepta, Biomarin, Acadia
By Joshua Rodriguez

Sarepta Therapeutics On Monday April 25, 2016 Sarepta Therapeutics (NASDAQ:SRPT) had a FDA advisory panel shoot down its drug Eteplirsen, used to treat patients with Duchenne Muscular Dystrophy --...

Show all (263)
Results: 7

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 231

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 263

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Apple
Continue with Google
or
Sign up with Email